# Sontag Family Trust

> Sontag Family Trust is a VC fund backing Biotechnology and Therapeutics. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Ponte Vedra Beach, United States
- Total investments: 6
- Last investment: Sep 2024
- Lead investor: 17%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/the-sontag-foundation
- Website: https://www.sontagfoundation.org

Sontag Family Trust is a charitable organization that focuses on Brain cancer research.

## Contacts

5 contacts available for Sontag Family Trust. Shizune tracks 1 team members at Sontag Family Trust. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sontag-family-trust?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 100% |
| Therapeutics | 2 | 33% |
| Biofuel | 1 | 17% |
| Medical | 1 | 17% |
| Robotics | 1 | 17% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 3 | 50% |
| Seed | 1 | 17% |
| Pre-Seed | 1 | 17% |
| Series D | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Scott Davis | Senior Associate, Life Sciences | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TippingPoint Biosciences | TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer. |  | Pre-Seed | Sep 04, 2024 |  |
| EnClear Therapies | EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will targetimproving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP). |  | Venture - Series Unknown | Sep 03, 2024 |  |
| MimiVax | MimiVax is a privately-held, clinical-stage biotechnology company that focuses on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. Its vaccines use survivin-targeting technology to target a cell-survival protein present in most cancers that enable healthcare providers to curetheir patients.The company was founded in 2012 and is headquartered in Buffalo, New York. |  | Venture - Series Unknown | Jan 09, 2024 |  |
| Modifi Bio | Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drugdevelopment methods. | $4.3M | Seed | Oct 16, 2023 |  |
| AiM Medical Robotics | AiM Medical Robotics developing a robotic system for use in neurosurgical procedures. The system is unique in that it is MRI compatible, allowing patients to be treated while in the MRI scanner. This gives physicians the ability to capture real-time imaging feedback to improve outcomes. Its system will help treat patients with Parkinson's,Epilepsy, Tremors, and brain cancer. |  | Venture - Series Unknown | Aug 22, 2022 |  |
| Agrivida | Agrivida is an agricultural biotechnology company that creates renewable, biomass-based alternative fuels, and raw materials. It develops corn varieties that are optimized for producing ethanol from corn stover. Ethanol is a clean-burning, renewable fuel that can be used as a gasoline additive or a gasoline replacement.It was founded in 2002 andis based in Cambridge, Massachusetts. | $12.3M | Series D | Jan 05, 2015 |  |

6 of 6 investments shown.

## Co-investors
- Brain Tumor Investment Fund — VC Fund, 2 deals together
- [Amgen Ventures](https://shizune.co/investors/profile/amgen-ventures) — VC Fund, 1 deal together
- [Bioverge](https://shizune.co/investors/profile/bioverge) — VC Fund, 1 deal together
- [Bright Capital](https://shizune.co/investors/profile/bright-capital) — VC Fund, 1 deal together
- [BrightEdge - American Cancer Society](https://shizune.co/investors/profile/brightedge-american-cancer-society) — VC Fund, 1 deal together
- [BrightEdge Fund](https://shizune.co/investors/profile/brightedge-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Sontag Family Trust invest in?

Sontag Family Trust invests primarily in Biotechnology, Therapeutics and Biofuel startups, most often at Venture - Series Unknown and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Sontag Family Trust?

Public channels for Sontag Family Trust include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Sontag Family Trust?

The team at Sontag Family Trust includes Scott Davis (Senior Associate, Life Sciences). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co